Comment
doi: 10.1016/S0140-6736(05)17876-3.
COX-2 selective inhibitors--important lessons learned
Affiliations
- PMID: 15705439
- DOI: 10.1016/S0140-6736(05)17876-3
Item in Clipboard
Comment
COX-2 selective inhibitors--important lessons learned
Lancet.
2005 Feb.
No abstract available
Comment in
-
Increased risk of cardiovascular events with coxibs and NSAIDs.Lancet. 2005 Apr 30-May 6;365(9470):1538-9. doi: 10.1016/S0140-6736(05)66448-3. Lancet. 2005. PMID: 15866300 No abstract available.
-
Increased risk of cardiovascular events with coxibs and NSAIDs.Lancet. 2005 Apr 30-May 6;365(9470):1538. doi: 10.1016/S0140-6736(05)66447-1. Lancet. 2005. PMID: 15866301 No abstract available.
Comment on
-
Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study.Lancet. 2005 Feb 5-11;365(9458):475-81. doi: 10.1016/S0140-6736(05)17864-7. Lancet. 2005. PMID: 15705456
Similar articles
-
Raising the safety bar--the FDA's coxib meeting.N Engl J Med. 2005 Mar 31;352(13):1283-5. doi: 10.1056/NEJMp058055. N Engl J Med. 2005. PMID: 15800221 No abstract available.
-
Concerns about COX-2 painkillers. They're easier on the stomach, potentially harder on your heart.Heart Advis. 2002 Jan;5(1):2. Heart Advis. 2002. PMID: 16145759 No abstract available.
-
COX-2 inhibitors--a lesson in unexpected problems.N Engl J Med. 2005 Mar 17;352(11):1131-2. doi: 10.1056/NEJMe058038. Epub 2005 Feb 15. N Engl J Med. 2005. PMID: 15713947 No abstract available.
-
[COX-2 inhibitors--one step forward and two steps back].Tidsskr Nor Laegeforen. 2005 Apr 7;125(7):875-8. Tidsskr Nor Laegeforen. 2005. PMID: 15815733 Review. Norwegian.
-
[COX-2 specific inhibitors: are NSAIDs and the stomach become reconcilied?].Gastroenterol Clin Biol. 2001 Apr;25(4 Suppl):B79-84. Gastroenterol Clin Biol. 2001. PMID: 11449148 Review. French. No abstract available.
Cited by
-
Turning liabilities into opportunities: Off-target based drug repurposing in cancer.Semin Cancer Biol. 2021 Jan;68:209-229. doi: 10.1016/j.semcancer.2020.02.003. Epub 2020 Feb 7. Semin Cancer Biol. 2021. PMID: 32044472 Free PMC article. Review.
-
Clinical use and pharmacological properties of selective COX-2 inhibitors.Eur J Clin Pharmacol. 2008 Mar;64(3):233-52. doi: 10.1007/s00228-007-0400-7. Epub 2007 Nov 13. Eur J Clin Pharmacol. 2008. PMID: 17999057 Review.
-
Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis.Arthritis Res Ther. 2006;8(5):R153. doi: 10.1186/ar2047. Arthritis Res Ther. 2006. PMID: 16995929 Free PMC article.
-
The effect of the withdrawal of rofecoxib on prescribing patterns of COX-2 inhibitors in Scotland.Br J Clin Pharmacol. 2006 Sep;62(3):366-8. doi: 10.1111/j.1365-2125.2006.02691.x. Br J Clin Pharmacol. 2006. PMID: 16934053 Free PMC article.
-
Selectivity of NSAIDs for COX-2 and cardiovascular outcome.Br J Clin Pharmacol. 2006 Aug;62(2):243-5. doi: 10.1111/j.1365-2125.2006.02620.x. Br J Clin Pharmacol. 2006. PMID: 16842401 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
